# Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

> **NCT05310227** · NA · WITHDRAWN · sponsor: **Children's National Research Institute**

## Conditions studied

- New Daily Persistent Headache (NDPH)

## Interventions

- **DEVICE:** Nerivio

## Key facts

- **NCT ID:** NCT05310227
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-01
- **Primary completion:** 2023-09-11
- **Final completion:** 2023-09-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The device became FDA approved during enrollment thereby nullifying the need to complete the trial. No clinical data was collected.
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05310227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05310227, "Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05310227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*